Consonance Capital Partners

Type

Private equity

Status

Active

Location

New York, United States

Total investments

7

Average round size

38M

Portfolio companies

7

Rounds per year

0.39

Lead investments

1

Exits

4

Stages of investment
Private Equity
Areas of investment
BiotechnologyDrug DiscoveryInformation TechnologyHealth CareSaaSManufacturingMedicalPharmaceuticalTherapeuticsEmergency Medicine

Summary

The leading representative office of defined VC is situated in the New York. The fund was located in North America if to be more exact in United States.

Besides, a startup needs to be aged more than 20 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Telesta Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Canada. We can highlight the next thriving fund investment areas, such as Therapeutics, Pharmaceutical.

The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Omega Funds, Boxer Capital.

The current fund was established by Mitchell Blutt. We also calculated 3 valuable employees in our database.

The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2016. The high activity for fund was in 2015.

Show more

Investor highlights

Geo focus
United States

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
7
Lead investments
1
Exits
4
Rounds per year
0.39
Investments by industry
  • Biotechnology (5)
  • Health Care (5)
  • Therapeutics (4)
  • Medical (3)
  • Drug Discovery (1)
  • Show 9 more
Investments by region
  • United States (5)
  • United Kingdom (1)
  • Canada (1)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
18
Avg. valuation at time of investment
92M
Group Appearance index
0.71
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Civic Eagle 11 May 2022 Software, B2B, SaaS Early Stage Venture 10M United States, Minnesota, Minneapolis

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.